Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study

Grodstein, 1994, Epidemiology of pelvic inflammatory disease, Epidemiology, 5, 234, 10.1097/00001648-199403000-00014

Diaz, 1993, Performance of copper T 200 in parous adolescents, Contraception, 48, 23, 10.1016/0010-7824(93)90062-C

Toivonen, 1991, Protective effect of intrauterine release of levonorgestrel on pelvic infection, Obstet Gynecol, 77, 261, 10.1097/00006250-199102000-00019

Milsom, 1989, The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD, Contraception, 41, 271, 10.1016/0010-7824(90)90068-7

Bergkvist, 1983, Treatment of menorrhagia with intrauterine release of progesterone, Br J Obstet Gynaecol, 90, 255, 10.1111/j.1471-0528.1983.tb08620.x

Milsom, 1991, Comparison of flurbiprofen, tranexamic acid and a levonorgestrel-releasing intrauterine device in treatment of idiopathic menorrhagia, Am J Obstet Gynecol, 164, 879, 10.1016/S0002-9378(11)90533-X

Sivin, 1994, Health during prolonged use of levonorgestrel 20 μg/d and copper TCu 380Ag intrauterine contraceptive devices, Fertil Steril, 61, 70, 10.1016/S0015-0282(16)56455-3

Belsey, 1988, The analysis of menstrual bleeding patterns, Contraception, 38, 129, 10.1016/0010-7824(88)90035-2

Sivin, 1990, Long-term contraception with the levonorgestrel 20 mcg/day (LNG 20) and the copper T 380Ag intrauterine device, Contraception, 42, 361, 10.1016/0010-7824(90)90046-X

Weström, 1980, Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries, Am J Obstet Gynecol, 138, 880, 10.1016/0002-9378(80)91077-7

Hubacher, 2001, Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women, N Engl J Med, 345, 561, 10.1056/NEJMoa010438

Henry-Suchet, 1996, Chlamydia trachomatis screening in family-planning centers, Eur J Contracept Reproduct Health Care, 1, 301, 10.3109/13625189609150675

Farley, 1992, Intrauterine devices and pelvic inflammatory disease, Lancet, i, 785, 10.1016/0140-6736(92)91904-M

Grimes, 1999, Prophylactic antibiotics for intrauterine device insertion, Contraception, 60, 57, 10.1016/S0010-7824(99)00071-2

den Tonkelaar, 1999, Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use, Contraception, 5, 357, 10.1016/S0010-7824(99)00043-8

Rosenberg, 1998, Oral contraceptive discontinuation, Am J Obstet Gynecol, 179, 577, 10.1016/S0002-9378(98)70047-X